These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10911468)

  • 1. [Valvular heart disease and primary pulmonary hypertension associated with fenfluramine-phentermine].
    Wolf I; Mouallem M; Farfel Z
    Harefuah; 1998 Dec; 135(11):515-7. PubMed ID: 10911468
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants].
    Goldstein SE; Levy Y; Shoenfeld Y
    Harefuah; 1998 Dec; 135(11):489-92, 568. PubMed ID: 10911459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fen-phen manufacturers, not physicians, are liable.
    Allen S; Henderson J
    Tex Med; 2000 May; 96(5):62-4. PubMed ID: 10843016
    [No Abstract]   [Full Text] [Related]  

  • 4. Longitudinal effects of fenfluramine-phentermine use.
    Bhattacharyya S; Constantin C; Davar J; Mikhailidis D
    Angiology; 2007 Dec-2008 Jan; 58(6):772-3; author reply 774. PubMed ID: 18216387
    [No Abstract]   [Full Text] [Related]  

  • 5. Further cases of valvular heart disease associated with fenfluramine-phentermine.
    Graham DJ; Green L
    N Engl J Med; 1997 Aug; 337(9):635. PubMed ID: 9280830
    [No Abstract]   [Full Text] [Related]  

  • 6. Valvular heart disease associated with fenfluramine-phentermine.
    Spitzer WO
    N Engl J Med; 1997 Dec; 337(24):1774-5; author reply 1775-6. PubMed ID: 9411251
    [No Abstract]   [Full Text] [Related]  

  • 7. Selections from current literature: pharmacological treatment of obesity.
    Connolly J; Verni C; Trilling J; Kelso E; Shiesha S
    Fam Pract; 1998 Feb; 15(1):88-93. PubMed ID: 9527304
    [No Abstract]   [Full Text] [Related]  

  • 8. Appetite suppressants and cardiac valvulopathy. Current clinical perspectives.
    Gross SB
    Adv Nurse Pract; 1999 Oct; 7(10):36-40. PubMed ID: 10808770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet pills redux.
    Curfman GD
    N Engl J Med; 1997 Aug; 337(9):629-30. PubMed ID: 9271487
    [No Abstract]   [Full Text] [Related]  

  • 10. Aminorex to Fen/Phen: an epidemic foretold.
    Tellier P
    Circulation; 1999 Dec; 100(25):e146; author reply e147. PubMed ID: 10604912
    [No Abstract]   [Full Text] [Related]  

  • 11. Valvular heart disease associated with fenfluramine-phentermine.
    Connolly HM; Crary JL; McGoon MD; Hensrud DD; Edwards BS; Edwards WD; Schaff HV
    N Engl J Med; 1997 Aug; 337(9):581-8. PubMed ID: 9271479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fen-phen's message to dentists.
    Hilsen K; Davis S; Iyer P
    J N J Dent Assoc; 1998; 69(1):37, 47. PubMed ID: 9584764
    [No Abstract]   [Full Text] [Related]  

  • 13. Anorexigen-related cardiopulmonary toxicity.
    Gross SB; Lepor NE
    Rev Cardiovasc Med; 2000; 1(2):80-9, 102. PubMed ID: 12457145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet drug-related cardiac valve disease: the Mayo Clinic echocardiographic laboratory experience.
    Teramae CY; Connolly HM; Grogan M; Miller FA
    Mayo Clin Proc; 2000 May; 75(5):456-61. PubMed ID: 10807073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose effect of fenfluramine-phentermine in the production of valvular heart disease.
    Tovar EA; Landa DW; Borsari BE
    Ann Thorac Surg; 1999 Apr; 67(4):1213-4. PubMed ID: 10320298
    [No Abstract]   [Full Text] [Related]  

  • 16. Valvular heart disease associated with fenfluramine-phentermine.
    Redmon B; Raatz S; Bantle JP
    N Engl J Med; 1997 Dec; 337(24):1773-4; author reply 1775. PubMed ID: 9411249
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pulmonary hypertension and heart valve diseases induced by fenfluramine? Hypothesis or certitude? Myth or reality?].
    Godeau P; Cherin P; Tellier P
    Rev Med Interne; 1998 Oct; 19(10):700-3. PubMed ID: 9827440
    [No Abstract]   [Full Text] [Related]  

  • 18. Valvular heart disease associated with fenfluramine-phentermine.
    Wolff FW
    N Engl J Med; 1997 Dec; 337(24):1774; author reply 1775-6. PubMed ID: 9411250
    [No Abstract]   [Full Text] [Related]  

  • 19. Obesity drugs and the heart.
    Connolly HM; McGoon MD
    Curr Probl Cardiol; 1999 Dec; 24(12):745-92. PubMed ID: 10609092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fen-phen and risk of valvular disease.
    SoRelle R
    Circulation; 1997 Sep; 96(6):1705-6. PubMed ID: 9323046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.